Artemis is a leading medical service provider with strong market positions in each of its regional clusters based on the highest medical quality and an outstanding reputation. The company was founded in 1999 and was acquired by Montagu in June 2015 alongside its founder, as a buy-and-build opportunity.
Montagu’s Investment Thesis for Artemis is to create a robust operating platform capable of delivering strong organic sales growth and accretive buy & build value, with significant further potential. Artemis has completed 45 add-ons of surgical clinics and conservative practices to date and has a strong pipeline of further acquisitions.
Recently appointed to the position of Chair for Artemis, Dr. Michael Lonsert serves on the Board of several Private Equity backed healthcare companies. He has worked as a director for companies of different size: Strathmann AG in Germany, Merck & Co., Inc. (EMEA Marketing Director, Managing Director), Hospira Inc. (Vice-President Europe) and Celesio AG (Member of the Executive Board). Michael’s business expertise is corporate strategy and turnaround management.
In his role as Chairman, the PhD in Health Science succeeds Hartmut Hain, who has left the company.